News
Mandatory Notification of Trade
21.11.2005 – Jamie Mather (through the company Nexus), Vice President and co-founder of Meridian International Group (MIG), and Daniel Laroque (through the company Cleverling), President and co-founder of MIG and board member of Nutri Pharma ASA, have on...
Read more about Mandatory Notification of TradeExtraordinary general meeting
25.11.2004 - The Extraordinary General Meeting of Nutri Pharma ASA today elected Knut Skabo to the Board of Directors. The decision was unanimous....
Read more about Extraordinary general meetingThird Quarter Report 2005
17.11.2005 – Nutri Pharma ASA (OSE: NUT) today reports revenues of NOK 19 mill in Q3 vs NOK 1.2 mill. in Q3 2004. As previously announced, Nutri Pharma ASA acquired 100% of the shareholding in Meridian International Group (MIG) with effect per 1 July 2005...
Read more about Third Quarter Report 2005Management change
04.11.2004 - As a result of the change in strategic focus announced in NUT`s Q3 report, the Board of Directors and CEO Eirik Ubøe have agreed that Ubøe is to leave is position as CEO of NUT....
Read more about Management changeProtokoll eks.ordinær generalforsamling
28.10.2005 - Generalforsamlingen i Nutri Pharma ASA har i dag den 28. oktober 2005 besluttet styrets forslag til vedtak i overenstemmelse med selskapets innkalling til aksjonærene sendt 14. oktober....
Read more about Protokoll eks.ordinær generalforsamlingThird Quarter Results 2004
19.10.2004 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for the first nine months of 2004 was NOK 9.8 million compared to a loss of NOK 8.5 million in the same period 2003....
Read more about Third Quarter Results 2004New date for Q3 2005 reporting
20.10.20005 - Nutri Pharma ASA announces that the Q3 2005 financial results will be released on 17 November 2005. ...
Read more about New date for Q3 2005 reportingNUT details for offer to aquire all outstanding shares
19.10.2004 - As announced on 14 October, Lars H. Høie has informed Nutri Pharma that he will make an offer to acquire all the outstanding shares in Nutri Pharma....
Read more about NUT details for offer to aquire all outstanding sharesNotice of Extraordinary General Meeting
14.10.2005 - An Extraordinary General Meeting of Nutri Pharma ASA will be held Friday 28 Oct. 2005, 10:00 a.m., offices of Nutri Pharma ASA, Kronprinsesse Märthas plass 1, Oslo, Norway....
Read more about Notice of Extraordinary General MeetingOpposition filed against a granted
01.09.2004 - NUT has been informed by the European Patent Office (EPO) that the EPO has received notice of opposition concerning a patent that has been granted to NUT for the European territory.....
Read more about Opposition filed against a grantedAmendment of terms regarding acquisition of MIG
29.09.2005 - Nutri Pharma ASA announces today amendment of certain terms in the agreement relating to acquisition of 100% of MIG, as announced by Nutri Pharma 2 June 2005....
Read more about Amendment of terms regarding acquisition of MIGFirst half results 2004
23.04.2004 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for the first half of 2004 was NOK 6.5 million compared to a profit of NOK 1.1 million in the first half of 2003....
Read more about First half results 2004First Half Report 2005
24.08.2005 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for the second quarter of 2005 was NOK -6,0 million compared to a loss of NOK -3,3 million in the second quarter of 2004....
Read more about First Half Report 2005Nutri Pharma has engaged
13.05.2004 - Nutri Pharma ASA has engaged Enskilda Securities to assist it in exploring and developing strategic alternatives.....
Read more about Nutri Pharma has engagedNutri Pharma ASA acquires 100% of Meridian International Group Ltd.
02.06.2005 - Nutri Pharma ASA announces today that it entered into an agreement on 1 June, 2005 to acquire 100% of the shares of the company Meridian International Group Ltd. (`MIG`)....
Read more about Nutri Pharma ASA acquires 100% of Meridian International Group Ltd.First quarter results 2004
27.04.2004 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for the first 3 months of 2004 was NOK 3.2 million compared to a profit of NOK 3.1 million in the first quarter of 2003. ....
Read more about First quarter results 2004Fourth quarter and preliminary results 2003
04.02.2004 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for 2003 was NOK 10.5 million compared to a loss of NOK 66.6 million in 2002....
Read more about Fourth quarter and preliminary results 2003Annual General Meeting
16.03.2005 - The Annual General Meeting (AGM) of Nutri Pharma ASA today approved the Board of Directors` proposal for annual accounts and directors` report including the Board of Directors` proposal for coverage of the loss for 2004.....
Read more about Annual General MeetingLicence Agreement with Allied Bakeries
16.01.2004 - Nutri Pharma ASA (OSE: NUT) has entered into licence agreement with Allied Bakeries - the leading bread manufacturer in the UK....
Read more about Licence Agreement with Allied BakeriesProduct Approval for Nutri Pro (Nutrilett) in Russia
14.03.2005 - Nutri Pharma ASA announces today that product approval for its soy based health and weight reduction product, sold under the trademark Nutrilett in the Nordic countries....
Read more about Product Approval for Nutri Pro (Nutrilett) in RussiaNUT Annual Report 2005
03.05.2005 - Nutri Pharma ASA`s Annual report for 2005 is approved by the Board of Directors . The 44 page report is available for download in Adobe Acrobat format below....
Read more about NUT Annual Report 2005Notice of Annual General Meeting
02.03.2005 - The annual general meeting of Nutri Pharma ASA will be held Tuesday 15 March 2005, 5:00 p.m., offices of Vogt & Wiig advokatfirma, Roald Amundsensgt. 6, Oslo, Norway....
Read more about Notice of Annual General MeetingNutri Pharma Patent upheld by European Patent Office
08.02.2005 - The Opposition Division of the European Patent Office has announced that Nutri Parma’s European Patent, No. 0902624, is valid under the European Patent Convention and has both novelty and inventive merit....
Read more about Nutri Pharma Patent upheld by European Patent OfficeFourth Quarter and Financial Results 2004
02.02.2005 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for 2004 was NOK 10.7 million compared to a loss of NOK 10.5 million in 2003....
Read more about Fourth Quarter and Financial Results 2004